Gut Check: How Cancer Affects Your Mood & What You Can Do
"New research reveals the surprising link between gastrointestinal cancer, muscle loss, and anxiety, offering hope for improved patient care."
Cancer cachexia, a syndrome marked by involuntary weight loss and muscle depletion, significantly impacts the quality of life for individuals with gastrointestinal (GI) cancers. This condition, characterized by the damage of muscle function, leads to clinical complications, reduced prognosis, and increased mortality.
Changes in body composition are frequently observed in GI cancer patients due to anorexia and severe weight loss, negatively affecting body perception. Muscle function loss (MFL) can further compromise independence and overall well-being, influencing daily activities and emotional health.
While psychological disorders like depression and anxiety are known challenges for cancer patients, recent research sheds light on a potential trigger: the loss of lean muscle mass. A new study investigates the prevalence of MFL in GI cancer patients and its correlation with anxiety and depression scores.
Muscle Weakness and Cachexia in Cancer
A 2024 review reports accumulating evidence that loss of muscle function can precede muscle atrophy, and examines cancer-associated muscle weakness independently of cachexia. It discusses proposed mechanisms, research methods, current interventions, and gaps and limitations in the field. Separate reviews describe cancer cachexia as a condition involving loss of muscle mass and function; one reports that it is responsible for 30% of all cancer deaths, while another characterizes it as a tumor-driven systemic metabolic syndrome associated with functional decline, reduced treatment tolerance, impaired quality of life, and poor survival.
The Muscle-Anxiety Connection: What the Study Revealed
A cross-sectional study was conducted with 71 adult patients diagnosed with gastrointestinal (GI) cancer. The study assessed muscle function loss (MFL) using the SARC-F questionnaire and evaluated anxiety and depression levels using the Hospital Anxiety and Depression Scale (HADS).
- 25% of GI cancer patients exhibited muscle function loss.
- Patients with MFL reported significantly higher anxiety and depression scores compared to the NMF group.
- A positive correlation was found between SARC-F scores and both anxiety and depression levels.
- After adjusting for sex and body weight, MFL showed a significant increase with the anxiety score.
- MFL was responsible for anxiety in 12% of the population studied.
Screening and Assessment of Muscle Loss
A 2026 scoping review aims to identify routinely assessed clinical measures associated with low muscle mass or muscle loss in cancer, to inform future screening and assessment. Its authors emphasize early identification as a way to enable timely intervention and mitigate adverse outcomes, including mortality. Other cited research uses the SARC-F questionnaire: one study classifies scores of 4 or higher as indicating sarcopenia risk, while a study in patients undergoing major urologic cancer surgery lists its five components as Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls, each scored from 0 to 2. A separate review notes anxiety may accompany illnesses associated with gut dysbiosis and inflammatory-neuroinflammatory processes, including cancer.
Muscle Loss, Treatment, and Supportive Care
A 2021 review reports that low muscle in people with cancer is associated with more treatment-related toxicities and predicts cancer-related and all-cause mortality. It describes multiple potential contributors to cancer-related muscle loss, including anorexia, hypogonadism, anemia, inflammation, malnutrition, and changes in skeletal-muscle protein turnover and metabolism. A 2025 prospective study set out to compare olanzapine with mirtazapine for cancer-associated cachexia-anorexia syndrome, which the study describes as affecting quality of life through weight loss, muscle wasting, and reduced treatment response. A separate systematic review examined progressive muscle relaxation interventions for depression, stress, anxiety, and quality of life in cancer patients.
Taking Charge: What This Means for Patients and Caregivers
This study underscores the importance of recognizing and addressing muscle function loss in GI cancer patients, not just for physical health but also for mental well-being. Early screening for sarcopenia and monitoring anxiety levels can lead to more holistic and effective care.
Cancer’s Wider Emotional and Physical Effects
Fear of cancer can become existential as people confront mortality and the possibility of losing their lives, according to a review of cancer’s mental-health impact. The review also notes that effects on relationships, family, and future plans can feel overwhelming and contribute to anxiety. A 2025 article attributes muscle loss in cancer to both the disease and treatment, describing inflammation-related processes that can promote muscle breakdown for energy, fat mobilization, and earlier feelings of fullness. These sources describe emotional and physical challenges, but do not establish that these mechanisms occur in every patient.
Experiences, Exercise, and Living With Cancer
A qualitative study used individual semi-structured interviews to explore how people with lung cancer experienced low muscle mass or muscle loss during treatment, including its effects on coping and self-care, and to learn their preferences for nutrition and exercise interventions. A 2025 study systematically evaluated different exercise intervention types for anxiety and depression in people with cancer, while noting that the optimal type remains unclear. One patient story describes Anthony, a Chicago-based architect diagnosed with stage 4 colon cancer in 2021, who lost 50 pounds—one-quarter of his body weight—over six months because of cachexia. Another source estimates that depression and anxiety frequently coexist in people diagnosed with cancer, with prevalence estimates of 20% to 25%.
Here are some steps patients and caregivers can consider:
<ul><li><b>Discuss concerns:</b> Talk to your doctor about muscle weakness, weight loss, or changes in mood.</li><li><b>Request screening:</b> Ask for a SARC-F assessment to evaluate muscle function.</li><li><b>Explore interventions:</b> If MFL is identified, discuss potential interventions such as nutritional support, exercise programs, or mental health counseling.</li></ul>